Remove BioTech Remove Data Remove Drug Development Remove Healthcare IT
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis.

Health IT 114
article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI is Shaping Drug Discovery at AION Labs

Healthcare IT Today

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery. Tell us what you think.

article thumbnail

Protai Adds $12 Million to Seed Round – Bringing the Total to $20 Million – to Build an Oncology Drug Discovery Pipeline

Healthcare IT Today

The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data acquisition as well as increase its discovery activities via pharma partnerships. These discoveries may be the key to significantly accelerating drug discovery and clinical development, lowering the time and costs of R&D.

article thumbnail

How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders

Healthcare IT Today

Today, however, biotechnology companies like Invitae are meeting the patient at the time of genetic diagnosis (with their permission) and enrolling them in real-world natural history data collection. This same process is now being done at the individual and family basis through a distributed biotech model.

article thumbnail

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Healthcare IT Today

This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials. Leveraging a wide range of parameters, this multifaceted approach is also valuable for drug repurposing efforts.

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. This data has historically been difficult to analyze en masse.

Health IT 106